<img height="1" width="1" src="https://www.facebook.com/tr?id=414339248965737&amp;ev=PageView &amp;noscript=1">

Eyes on Research

Patient Centric Clinical Trials: Why Transportation Is a Timeline Risk

20/20 Onsite

How to Reduce Patient Dropout Rates in Clinical Trials

20/20 Onsite

BCVA, OCT, and IOP Testing in Clinical Trials: Common Operational Mistakes to Avoid

By 20/20 Onsite

How Small Operational Gaps Create Big Endpoint Risk in BCVA, OCT, and IOP Testing Key Takeaways BCVA, OCT, and IOP endpoints drift when setup, technique, timing, and documentation are not controlled... Read More

What Sponsors Need from Decentralized Clinical Trial Platforms for Ophthalmic Endpoints

By 20/20 Onsite

Read More

Site Initiation Visits for Clinical Trials: Ocular Endpoint Planning for Sponsors and CROs

By 20/20 Onsite

Read More

At-Home Clinical Trials: When At-Home Ophthalmic Exams Make Sense

By 20/20 Onsite

At-home clinical trials have the potential to improve how research studies are conducted and the level of participation they receive. Learn more about this option and whether it’s appropriate for... Read More

Hybrid Clinical Trials: How to Split Ophthalmic Visits Across Home, Hub, and Site

By 20/20 Onsite

Hybrid clinical trials combine traditional site-based research with decentralized trial (DCT) elements. These can include remote monitoring via apps and wearable technology, as well as virtual... Read More

2025 Recap: How 20/20 Onsite Drove Clinical Research Innovation by Transforming Patient Retention, Trial Efficiency, and Sponsor Confidence

By 20/20 Onsite

The most powerful shift in clinical research this year:Bringing the clinic to the patient is no longer optional; it's essential for patient enrollment and retention. 2025 proved that sponsors don't... Read More

Improving Diversity in Clinical Trials: How Mobile Clinics Remove Barriers to Participation

By 20/20 Onsite

Why Diversity in Clinical Trials Remains a Critical Gap Diversity in clinical trials is vital to ensure treatments are safe for everyone. Clinical trial participants come from all backgrounds,... Read More

Virtual Clinical Trials: Feasibility for Ophthalmic Endpoints (BCVA, OCT, IOP)

By 20/20 Onsite

Why the Model Matters (Virtual vs. Hybrid With Onsite/Mobile Hubs) Traditional clinical trials often face challenges recruiting participants from diverse backgrounds because there can be barriers... Read More